CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies

Download All
In this engaging online program, watch experts discuss emerging strategies and current best practices in CAR T-cell therapy for patients with lymphomas, leukemias, and myelomas. Download slides with all the key data, view the on-demand Webcast, and join the discussion with expert-authored commentaries and podcasts.
Frederick L. Locke, MD
Noopur Raje, MD

Podcast

Listen to Noopur Raje, MD, answer audience questions from a live CCO Webinar focused on emerging strategies in the use of CAR T-cell therapy for patients with multiple myeloma and key toxicities associated with CAR T-cell therapy.

Noopur Raje, MD Released: March 12, 2021

Download this slideset for key insights from our podcast featuring expert answers to questions on emerging strategies in the use of CAR T-cell therapy for patients with multiple myeloma and key toxicities associated with CAR T-cell therapy.

Noopur Raje, MD Released: March 12, 2021

Listen to Frederick L. Locke, MD, answer audience questions from a live CCO Webinar focused on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas.

Frederick L. Locke, MD Released: March 18, 2021
Provided by Medical College of Wisconsin in partnership with Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Kite Pharma

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue